タンパク質特性評価・同定市場：構成要素、用途、エンドユーザー別-2025-2030年世界予測

タンパク質特性評価・同定市場は、2023年に210億6,000万米ドルと評価され、2024年には255億米ドルに達すると予想され、CAGR 21.88％で成長し、2030年には841億6,000万米ドルになると予測されています。

タンパク質の特性解析と同定には、タンパク質の構造、機能、相互作用を決定するための分析プロセスが含まれ、生物学的プロセスの理解と治療法の開発に不可欠です。これらのプロセスの必要性は、創薬、疾病診断、治療モニタリングに役立つ、医薬品、バイオテクノロジー、診断などの様々な最終用途産業での用途にあります。市場の成長は、プロテオミクス研究への投資の増加、個別化医療への需要の高まり、質量分析計やクロマトグラフィーなどの分析技術の進歩によってもたらされます。タンパク質分析における人工知能や機械学習の統合により、精度と効率が向上し、研究者が標的治療やバイオマーカー探索の革新につながる可能性があり、機会は拡大しています。

市場の成長は、タンパク質分析のスピードと精度を向上させる技術的進歩や、高度な診断ツールを必要とする慢性疾患の蔓延の増加に大きく影響されています。しかし、装置や高度な分析に必要な技術的専門知識のコストが高く、中小企業や予算が限られている研究所にとっては障壁となる可能性があります。また、複雑なデータセットには強固な分析フレームワークが必要であり、データ管理と解釈にも課題が生じる。

新たな革新的分野としては、新規タンパク質修飾の探索、シングルセル・プロテオミクス、ポータブル診断ツールの開発などが挙げられます。これらをバイオインフォマティクスと組み合わせることは、大規模なタンパク質データを活用し、タンパク質の機能についてより深い洞察を得るために極めて重要です。費用対効果の高い技術や手法の調査は、アクセスを民主化し、市場範囲を拡大する可能性もあります。市場競争力を維持するために、市場関係者は最先端の計算技術を統合するテクノロジー企業との共同事業を優先すべきです。全体として、市場は大幅な成長の可能性を秘めているが、成功の鍵は、運営上の課題を克服し、効率的かつ革新的なタンパク質研究ソリューションを育成するために技術の進歩を活用できるかどうかにかかっています。

市場力学：急速に進化するタンパク質特性評価・同定市場の主要市場インサイトを公開

タンパク質特性評価・同定市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化医薬品の製造に伴う潜在需要
  • 希少疾患や新規疾患に対する創薬ニーズの高まり
  • 臨床研究開発への投資拡大
• 市場抑制要因
  • 熟練した専門家の不足
• 市場機会
  • プロテオミクスの研究開発の活発化
  • 製薬企業やバイオテクノロジー企業の進出増加
• 市場の課題
  • 複雑なプロセスと長い分析時間

ポーターの5つの力：タンパク質特性評価・同定市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：タンパク質特性評価・同定市場における外部からの影響の把握

外部マクロ環境要因は、タンパク質特性評価・同定市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析タンパク質特性評価・同定市場における競合情勢の把握

タンパク質特性評価・同定市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスタンパク質特性評価・同定市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、タンパク質特性評価・同定市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨タンパク質特性評価・同定市場における成功への道筋を描く

タンパク質特性評価・同定市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズ医薬品の製造に関連する潜在的な需要
    • 希少疾患や新規疾患に対する新薬発見の必要性が高まる
    • 臨床調査と開発への投資の増加
  • 抑制要因
    • 熟練した専門家の不足
  • 機会
    • プロテオミクスの研究開発の活発化
    • 製薬企業とバイオテクノロジー企業の拡大
  • 課題
    • 複雑なプロセスと長い分析時間
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 タンパク質特性評価・同定市場：コンポーネント別

• 消耗品
  • クロマトグラフィー消耗品
  • 電気泳動消耗品
  • 免疫測定用消耗品
  • 質量分析消耗品
• 機器
  • クロマトグラフィー機器
  • 電気泳動装置
  • ラベルフリー検出装置
  • 分光機器
• サービス

第7章 タンパク質特性評価・同定市場：用途別

• 臨床診断
• 医薬品の発見と開発

第8章 タンパク質特性評価・同定市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第9章 南北アメリカのタンパク質特性評価・同定市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のタンパク質特性評価・同定市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのタンパク質特性評価・同定市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advion, Inc.
• Agilent Technologies Inc.
• Alphalyse Inc.
• Analytik Jena AG
• CBS Scientific Company Inc.
• Cleaver Scientific Ltd.
• Danaher Corporation
• Horiba, Ltd.
• Labrepco, Inc.
• MS Bioworks LLC
• Promega Corporation
• Proteome Factory AG
• QIAGEN N.V.
• Rigaku Corporation
• The Merck Group
• The Sartorius Group
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET RESEARCH PROCESS
• FIGURE 2. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CHROMATOGRAPHY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY ELECTROPHORESIS CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY IMMUNOASSAY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY MASS SPECTROMETRY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY LABEL-FREE DETECTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 46. CANADA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 47. CANADA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 73. CHINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 74. CHINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 78. INDIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 79. INDIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 164. ITALY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. ITALY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 184. POLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 185. POLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 189. QATAR PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. QATAR PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

The Protein Characterization & Identification Market was valued at USD 21.06 billion in 2023, expected to reach USD 25.50 billion in 2024, and is projected to grow at a CAGR of 21.88%, to USD 84.16 billion by 2030.

Protein characterization and identification encompass the analytical processes used to determine the structure, function, and interactions of proteins, integral to understanding biological processes and developing therapeutic solutions. The necessity of these processes lies in their application across various end-use industries such as pharmaceuticals, biotechnology, and diagnostics, where they aid in drug discovery, disease diagnosis, and therapeutic monitoring. The market's growth is driven by increasing investments in proteomics research, rising demand for personalized medicine, and advancements in analytical techniques like mass spectrometry and chromatography. Opportunities are expanding with the integration of artificial intelligence and machine learning in protein analysis, which enhances accuracy and efficiency and could lead researchers to innovate targeted therapies and biomarker discovery.

Market growth is significantly influenced by technological advancements that improve the speed and accuracy of protein analysis, as well as the increasing prevalence of chronic diseases that necessitate advanced diagnostic tools. However, limitations include the high cost of instrumentation and the technical expertise required for sophisticated analysis, which could act as barriers for smaller players and laboratories with limited budgets. Challenges also arise in data management and interpretation, where complex data sets require robust analytical frameworks.

Emerging areas of innovation include the exploration of novel protein modifications, single-cell proteomics, and the development of portable diagnostics tools. Combining these with bioinformatics is crucial for harnessing large-scale protein data, providing more profound insights into protein functions. Research into cost-effective technologies and methods could also democratize access, enhancing the market scope. Market actors should prioritize collaborative ventures with technology firms to integrate cutting-edge computational technologies to stay competitive. Overall, while the market presents substantial growth potential, success hinges on overcoming operational challenges and leveraging technological advancements to foster efficient and innovative protein research solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Protein Characterization & Identification Market

The Protein Characterization & Identification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Potential demand associated with manufacturing of personalized medications
  • Rising need of drug discoveries for rare along with novel diseases
  • Growing investments for clinical research and developments
• Market Restraints
  • Unavailability of skilled professionals
• Market Opportunities
  • Upsurging research and development for proteomics
  • Increasing expansions of pharmaceutical and biotechnological companies
• Market Challenges
  • Complex process coupled with longer time of analysis

Porter's Five Forces: A Strategic Tool for Navigating the Protein Characterization & Identification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Protein Characterization & Identification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Protein Characterization & Identification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Protein Characterization & Identification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Protein Characterization & Identification Market

A detailed market share analysis in the Protein Characterization & Identification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Protein Characterization & Identification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Protein Characterization & Identification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Protein Characterization & Identification Market

A strategic analysis of the Protein Characterization & Identification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Protein Characterization & Identification Market, highlighting leading vendors and their innovative profiles. These include Advion, Inc., Agilent Technologies Inc., Alphalyse Inc., Analytik Jena AG, CBS Scientific Company Inc., Cleaver Scientific Ltd., Danaher Corporation, Horiba, Ltd., Labrepco, Inc., MS Bioworks LLC, Promega Corporation, Proteome Factory AG, QIAGEN N.V., Rigaku Corporation, The Merck Group, The Sartorius Group, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Protein Characterization & Identification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Chromatography Consumables, Electrophoresis Consumables, Immunoassay Consumables, and Mass Spectrometry Consumables. The Instruments is further studied across Chromatography Instruments, Electrophoresis Instruments, Label-Free Detection Instruments, and Spectroscopy Instruments.
• Based on Application, market is studied across Clinical Diagnosis and Drug Discovery & Development.
• Based on End-User, market is studied across Academic Research Institutions, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Potential demand associated with manufacturing of personalized medications
    • 5.1.1.2. Rising need of drug discoveries for rare along with novel diseases
    • 5.1.1.3. Growing investments for clinical research and developments
  • 5.1.2. Restraints
    • 5.1.2.1. Unavailability of skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Upsurging research and development for proteomics
    • 5.1.3.2. Increasing expansions of pharmaceutical and biotechnological companies
  • 5.1.4. Challenges
    • 5.1.4.1. Complex process coupled with longer time of analysis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Protein Characterization & Identification Market, by Component

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Chromatography Consumables
  • 6.2.2. Electrophoresis Consumables
  • 6.2.3. Immunoassay Consumables
  • 6.2.4. Mass Spectrometry Consumables
• 6.3. Instruments
  • 6.3.1. Chromatography Instruments
  • 6.3.2. Electrophoresis Instruments
  • 6.3.3. Label-Free Detection Instruments
  • 6.3.4. Spectroscopy Instruments
• 6.4. Services

7. Protein Characterization & Identification Market, by Application

• 7.1. Introduction
• 7.2. Clinical Diagnosis
• 7.3. Drug Discovery & Development

8. Protein Characterization & Identification Market, by End-User

• 8.1. Introduction
• 8.2. Academic Research Institutions
• 8.3. Contract Research Organizations
• 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Protein Characterization & Identification Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Protein Characterization & Identification Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Protein Characterization & Identification Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advion, Inc.
• 2. Agilent Technologies Inc.
• 3. Alphalyse Inc.
• 4. Analytik Jena AG
• 5. CBS Scientific Company Inc.
• 6. Cleaver Scientific Ltd.
• 7. Danaher Corporation
• 8. Horiba, Ltd.
• 9. Labrepco, Inc.
• 10. MS Bioworks LLC
• 11. Promega Corporation
• 12. Proteome Factory AG
• 13. QIAGEN N.V.
• 14. Rigaku Corporation
• 15. The Merck Group
• 16. The Sartorius Group
• 17. Thermo Fisher Scientific, Inc.